Yaying Du

Yaying Du

Yale University

H-index: 14

North America-United States

Contact Yaying Du

About Yaying Du

Yaying Du, With an exceptional h-index of 14 and a recent h-index of 14 (since 2020), a distinguished researcher at Yale University, specializes in the field of cancer progression and anti-tumor immunity.

His recent articles reflect a diverse array of research interests and contributions to the field:

Directed differentiation of human embryonic stem cells into parathyroid cells and establishment of parathyroid organoids

HDAC Inhibitor Regulates the Tumor Immune Microenvironment via Pyroptosis in Triple Negative Breast Cancer

Decoding the past and future of bone metastasis from breast cancer: A bibliometric analysis from 2003 to 2022

Compositions and methods for engineering and selection of car t cells with desired phenotypes

Massively parallel knock-in engineering of human T cells

Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery

A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy

MiR-205-5p/GGCT attenuates growth and metastasis of papillary thyroid cancer by regulating CD44

Yaying Du Information

University	Yale University
Position	Department of Genetics School of Medicine
Citations(all)	955
Citations(since 2020)	939
Cited By	279
hIndex(all)	14
hIndex(since 2020)	14
i10Index(all)	17
i10Index(since 2020)	17
Email	Access Email
University Profile Page	Yale University
Google Scholar	View Google Scholar Profile

Yaying Du Skills & Research Interests

cancer progression and anti-tumor immunity

Top articles of Yaying Du

Directed differentiation of human embryonic stem cells into parathyroid cells and establishment of parathyroid organoids

Biotechnology journal

2017/12

Qian Zhu

H-Index: 12

Mingming Li

H-Index: 4

Chuan Yan

H-Index: 1

Rong Gao

H-Index: 12

Yu Zou

H-Index: 5

Zhiyuan Gong

H-Index: 39

Tong Cao

H-Index: 2

HDAC Inhibitor Regulates the Tumor Immune Microenvironment via Pyroptosis in Triple Negative Breast Cancer

2024/1/2

Xue Yang

H-Index: 23

Ge Wang

H-Index: 19

Yaying Du

H-Index: 7

Tao Xu

H-Index: 10

Decoding the past and future of bone metastasis from breast cancer: A bibliometric analysis from 2003 to 2022

Asian journal of surgery

2023/12

Yaying Du

H-Index: 7

Compositions and methods for engineering and selection of car t cells with desired phenotypes

2023/9/28

Massively parallel knock-in engineering of human T cells

Nature Biotechnology

2023/9

Yaying Du

H-Index: 7

Zhiyuan Chu

H-Index: 1

Paul Clark

H-Index: 10

Hongyu Zhao

H-Index: 15

Sarah Slavoff

H-Index: 13

Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery

BMC Endocrine Disorders

2023/5/19

Xue Yang

H-Index: 23

Ge Wang

H-Index: 19

Tao Xu

H-Index: 10

Yaying Du

H-Index: 7

A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy

Cell metabolism

2022/4/5

Lupeng Ye

H-Index: 11

Lei Peng

H-Index: 2

Guangchuan Wang

H-Index: 21

Yaying Du

H-Index: 7

Paul Clark

H-Index: 10

MiR-205-5p/GGCT attenuates growth and metastasis of papillary thyroid cancer by regulating CD44

Endocrinology

2022/4/1

Jun Wang

H-Index: 10

Tao Xu

H-Index: 10

Ge Wang

H-Index: 19

Xue Yang

H-Index: 23

CAR-T cells targeting TSHR demonstrate safety and potent preclinical activity against differentiated thyroid cancer

The Journal of Clinical Endocrinology & Metabolism

2022/4/1

Xiang Zhou

H-Index: 10

Ge Wang

H-Index: 19

Shuyu Li

H-Index: 14

Tao Xu

H-Index: 10

Xue Yang

H-Index: 23

Zhifang Yang

H-Index: 13

Yaying Du

H-Index: 7

Regulation of antitumor miR-205 targets oncogenes: Direct regulation of lymphoid specific helicase and its clinical significance

Life Sciences

2022/11/15

Xue Yang

H-Index: 23

Ge Wang

H-Index: 19

Shuyu Li

H-Index: 14

Tao Xu

H-Index: 10

Ziyao Zhang

H-Index: 1

Yaying Du

H-Index: 7

Current landscape of personalized clinical treatments for triple-negative breast cancer

2022/9/16

Jun Zhang

H-Index: 11

Yu Xia

H-Index: 2

Xiaomei Zhou

H-Index: 3

Honghao Yu

H-Index: 1

Yaying Du

H-Index: 7

Qi Zhang

H-Index: 5

Cyclin-dependent kinase inhibitors function as potential immune regulators via inducing pyroptosis in triple negative breast cancer

Frontiers in Oncology

2022/6/8

Tao Xu

H-Index: 10

Zhen Wang

H-Index: 42

Jiahao Liu

H-Index: 2

Ge Wang

H-Index: 19

Yaying Du

H-Index: 7

Yu Xia

H-Index: 2

A miR-205-5p/GGCT/CD44 axis controls the progression of papillary thyroid cancer

2021/10/18

Jun Wang

H-Index: 10

Tao Xu

H-Index: 10

Ge Wang

H-Index: 19

Xue Yang

H-Index: 23

CAR-T cells targeting thyroid-stimulating hormone receptor (TSHR) demonstrate safety and potent preclinical activity against differentiated thyroid cancer

medRxiv

2021/5/18

Xiang Zhou

H-Index: 10

Ge Wang

H-Index: 19

Shuyu Li

H-Index: 14

Tao Xu

H-Index: 10

Xue Yang

H-Index: 23

Zhifang Yang

H-Index: 13

Yaying Du

H-Index: 7

LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15

BMC molecular and cell biology

2020/12

Yun Liu

H-Index: 36

Yaying Du

H-Index: 7

Xiaopeng Hu

H-Index: 12

Tmem158 may serve as a diagnostic biomarker for anaplastic thyroid carcinoma: an integrated bioinformatic analysis

Current medical science

2020/12

Tao Xu

H-Index: 10

Rui Zhang

H-Index: 43

Ge Wang

H-Index: 19

CRISPR-GEMM pooled mutagenic screening identifies KMT2D as a major modulator of immune checkpoint blockade

Cancer discovery

2020/12/1

Guangchuan Wang

H-Index: 21

Lvyun Zhu

H-Index: 11

Zhigang Bai

H-Index: 16

Lupeng Ye

H-Index: 11

Feifei Zhang

H-Index: 7

Xiaoya Zhang

H-Index: 2

Yaying Du

H-Index: 7

Zhiyuan Chu

H-Index: 1

Paul Clark

H-Index: 10

The association between Foxp3 polymorphisms and risk of graves' disease: A systematic review and meta-analysis of observational studies

2020/6/16

ZW10 interacting kinetochore protein may serve as a prognostic biomarker for human breast cancer: An integrated bioinformatics analysis

Oncology Letters

2020/3/1

Ge Wang

H-Index: 19

RETRACTED ARTICLE: MicroRNA-423 Drug Resistance and Proliferation of Breast Cancer Cells by Targeting ZFP36

OncoTargets and therapy

2020/1/24

Yun Liu

H-Index: 36

Yaying Du

H-Index: 7

Xiaopeng Hu

H-Index: 12

See List of Professors in Yaying Du University(Yale University)

academic-engine

Useful Links

List of top 50 universities

List of top 100 universities

List of top 500 universities

Find Professors Email

Find Universities Email

CUFinder Academic Engine